
Prime Stock Update: Why this quasi-equity instrument continues in our ‘Buy’ list
Why this listed InvIT is our pick!

Why this listed InvIT is our pick!

Find out if you should invest in the Ather Energy IPO!

Why the reciprocal tariff was flawed to begin with and what happens next – find out here!

Domestic slowdown and tariff fears have led to a correction in this quality stock!

Correction offers an attractive entry point into this auto maker that is on a strong footing!

Correction makes valuation attractive again!

Find out why we think you should lock into your gains on this Prime Stock!

Successful execution of a new strategy could prove to be rewarding for shareholders. Find out more in the report!

A sharp correction despite fundamentals remaining intact in the case of this Prime Stock!

Find out why this stock is making its way into our BUY list for the second time!

With Trump’s talk of tariffs dominating headlines, if you too have joined in the quest for stocks that may offer immunity from this threat then this vaccine-maker is one of our picks – Glaxosmithkline Pharmaceuticals Limited. This MNC pharma player has an enduring suite of brands that have withstood challenges, such as the advent of […]

Results update for 13 of our Prime Stocks.
Hold On
You are being redirected to another page,